Safety Substantiation for Cosmetics
To commercialize in the U.S. market, cosmetic companies must demonstrate the safety of their products with solid documentation. Sobel supports you by compiling scientific data, studies, and analyses into a compliant FDA safety substantiation file—aligned with MoCRA and inspection-ready for the FDA.
- Cosmetic manufacturers and brand owners selling in the U.S.
- Foreign companies exporting cosmetics to the U.S. market.
- Businesses preparing for FDA inspections under MoCRA.
- Companies that lack complete or organized safety documentation.
Count on Sobel to prepare your FDA safety substantiation file, compiling scientific data, studies, and analyses into a structured dossier that demonstrates your cosmetic product is safe and compliant with MoCRA.
Why do you need this service?
MoCRA requires every cosmetic sold in the U.S. to have documented safety substantiation available for FDA review.
Missing or poorly structured data increases the risk of detentions, recalls, and regulatory enforcement.
Comprehensive documentation ensures your products are inspection-ready and strengthens trust with consumers.
How Sobel supports your FDA safety substantiation
Strong safety substantiation goes beyond gathering documents—it requires regulatory expertise and clear scientific presentation.
With Sobel, building your FDA safety substantiation file becomes structured, efficient, and compliant.
Related
Services
MoCRA requires that every cosmetic product has documented proof of safety, available for FDA inspection.
To keep your cosmetic in full compliance, Sobel offers additional services to support your journey.
Gap Analysis
Pre-registration review of cosmetic documents to identify gaps and guide compliance.
Update of GMP Manual
We help cosmetic manufacturers revise documentation for full compliance.
Cosmetic Registration
Cosmetic Registration and Product Listing according to the FDA regulamentations.
Build your FDA Safety Substantiation with Sobel
Sobel helps you compile and present all required documentation, creating an inspection-ready dossier that demonstrates your products are safe.
So, don’t risk delays or non-compliance when the FDA requests your safety file! Talk to our team today and secure FDA-compliant safety substantiation for your cosmetics.
1. What is safety substantiation under MoCRA?
Safety substantiation is the requirement that every cosmetic product sold in the U.S. has documented evidence proving it is safe under its intended use. This file may include toxicological studies, literature reviews, and expert analyses. The FDA can request to review it at any time, so companies must be prepared.
2. Does every cosmetic need a safety substantiation file?
Yes. MoCRA makes safety substantiation mandatory for all cosmetics marketed in the United States, regardless of whether they are manufactured locally or abroad. Having this documentation ensures your products remain compliant and available for sale in the U.S. market.
3. What happens if I don’t have proper documentation?
If you cannot provide adequate safety substantiation during an FDA inspection or inquiry, your company may face warning letters, recalls, or import detentions. Incomplete or disorganized files also delay market entry and can harm your reputation with regulators and business partners.
4. Can Sobel generate new studies or lab tests?
No. Sobel does not perform laboratory testing or clinical studies. Instead, we compile, review, and organize the data you already have—such as toxicological reports, published studies, and expert assessments—into a structured FDA safety substantiation file.
5. How does Sobel add value to the process?
Sobel ensures that your existing safety data is presented in a way that meets FDA expectations and MoCRA requirements. Our specialists identify gaps, suggest corrective actions, and deliver a clear, inspection-ready dossier. This reduces compliance risks and allows your team to stay focused on innovation.
